一种基于核酸的超分子水凝,集成局部自传递和免疫调节,用于牙周炎治疗
Fangyuan Shuai1, Yijia Yin1, Yufei Yao1
1State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Research Unit of Oral Carcinogenesis and Management & Department of Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, PR China.
Biomaterials
|December 20, 2024
概括
一种新的水凝提供8-aminoguanosine (8AG),通过减少炎症和骨质损失来治疗牙周炎. 这种可注射材料为这种常见的口腔疾病提供了有前途的局部治疗方法.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 牙周病学 牙周病学
背景情况:
- 牙周炎是一种普遍的炎症性口腔疾病,导致牙周破坏.
- 细菌感染引发免疫过度激活,导致持续的炎症和骨质损失.
研究的目的:
- 开发一种用于局部牙周炎治疗的免疫调节超分子凝.
- 为了研究水凝的传递8-aminoguanosine (8AG) 和调节免疫反应的能力.
主要方法:
- 合成了一种基于乙烯酸乙烯的8AGPB水凝,使用单方法.
- 评估的水凝特性:稳定性,自我愈合性,可注射性和生物相容性.
- 评估了8AG释放及其对巨细胞信号通路 (MAPK,NF-κB) 和氧化应激 (ROS) 的影响.
主要成果:
- 8AGPB水凝显示出出色的物理和生物特性.
- 释放的8AG调节了巨细胞极化 (M1/M2比) 和减少了促炎因素.
- 在体内,水凝抑制了炎症透和骨质结晶活动,改善了小鼠模型中的牙周破坏.
结论:
- 8AGPB超分子凝是一种有前途的可注射平台,用于局部8AG输送.
- 这种策略通过免疫调节和减少氧化损伤有效治疗牙周炎.
- 为未来口腔护理中的局部抗炎系统提供了潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


